Albertsons Companies (ACI) Proxy Filing summary
Event summary combining transcript, slides, and related documents.
Proxy Filing summary
1 Dec, 2025Executive summary
Annual meeting scheduled for August 7, 2025, to elect 11 directors, ratify Deloitte and Touche as auditor, hold a say-on-pay vote, and consider three shareholder proposals.
New CEO Susan Morris, appointed May 1, 2025, outlined strategic pillars: digital engagement, media business growth, customer value, technology modernization, and productivity improvements.
Company targets $1.5 billion in productivity savings from 2025-2027 to reinvest in growth and offset inflation.
ESG initiatives include a goal of 1.5 billion additional meals by 2030 and significant food and financial support to communities.
Voting matters and shareholder proposals
Board recommends voting FOR all director nominees, auditor ratification, and executive compensation; AGAINST all three shareholder proposals.
Shareholder proposals: (1) food waste reporting, (2) human rights policy and due diligence, (3) report on risks of state reproductive health policies.
Board opposes proposals, citing existing initiatives, reporting practices, and resource considerations.
Board of directors and corporate governance
Board consists of 11 members, 73% independent, with diverse skills in governance, finance, technology, and retail.
Separate CEO and Chair roles; majority voting standard; annual board and committee evaluations.
Cerberus Capital Management retains rights to designate up to four directors based on ownership.
Board committees: Audit, Compensation, Governance, Technology, and Finance, all with independent oversight.
Latest events from Albertsons Companies
- Q3 delivered solid sales and digital growth, but faces post-merger litigation and margin pressure.ACI
Q3 202410 Jan 2026 - Identical sales and digital growth lifted revenue, but margins narrowed amid ongoing investments.ACI
Q1 20259 Jan 2026 - Q3 2025 saw 2.4% identical sales growth, strong digital gains, and major capital actions.ACI
Q3 20257 Jan 2026 - Q2 2025 saw 2.0% revenue growth, higher net income, and a $750M share buyback announcement.ACI
Q2 20257 Jan 2026 - Q4 delivered strong digital and pharmacy growth, but margin pressure tempers 2025 optimism.ACI
Q4 202419 Dec 2025 - Annual meeting to vote on directors, auditor, and pay, with focus on merger, governance, and ESG.ACI
Proxy Filing1 Dec 2025 - Annual proxy statement outlines voting items and confirms standard shareholder meeting.ACI
Proxy Filing1 Dec 2025 - Definitive additional proxy materials filed for shareholder voting, with no fee required.ACI
Proxy Filing1 Dec 2025 - All directors attended at least 75% of board and committee meetings in fiscal 2024.ACI
Proxy Filing1 Dec 2025